Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
PR Newswire (Apr 24, 2013)
-
-
-
PR Newswire (Feb 13, 2013)
-
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
PR Newswire (Dec 10, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
Profiting With Prolor During Market TurbulenceEricFinance • Tue, Jul 10, 2012 -
-
-
Interested In A Biotech Stock For Growth? Consider ProlorJohn Mylant • Wed, Jun 27, 2012
-
-
-
-
-
-
Why BioPharma Is Eyeing ProlorTakeover Analyst • Tue, Mar 6, 2012 -
-
-
-
-
-
-
-
-
-
-
Stock Watch Wednesday, 12 DecemberVFC's Stock House • Wed, Dec 12, 2012
-
-
-
Therapeutic Proteins Offer New Investment OpportunitiesCris Frangold • Sat, Nov 24, 2012
-
-
These 5 Insider Favorites Are Trading At Big Discounts To Target PriceKapitall • Tue, Nov 13, 2012 -
-
-
-
-
-
Weekly Stock Watch: Week Of July 9VFC's Stock House • Sun, Jul 8, 2012
-
Weekly Stock Watch, Week Of July 1VFC's Stock House • Mon, Jul 2, 2012
There are no Transcripts on PBTH.
-
PR Newswire (Apr 24, 2013)
-
PR Newswire (Feb 13, 2013)
-
PR Newswire (Dec 10, 2012)
-
PR Newswire (Nov 13, 2012)
-
PR Newswire (Oct 3, 2012)
-
PR Newswire (Sep 21, 2012)
-
Data From Phase II Trial of Prolor Biotech's Long-acting Human Growth Hormone Presented at Endo 2012PR Newswire (Jun 26, 2012)
-
PR Newswire (May 30, 2012)
-
PR Newswire (May 11, 2012)
PBTH vs. ETF Alternatives
Company Description
Currently, there's no company description for PBTH.
